TITLE

Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses

AUTHOR(S)
Nasser, S M; Bell, G S; Hawksworth, R J; Spruce, K E; MacMillan, R; Williams, A J; Lee, T H; Arm, J P
PUB. DATE
August 1994
SOURCE
Thorax;Aug1994, Vol. 49 Issue 8, p743
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66124155

 

Related Articles

  • The β2 receptor and airway hyper-responsiveness: are sensory nerves involved? Page, Clive // Thorax;Sep2009, Vol. 64 Issue 9, p2 

    The article discusses the effect of β2 receptor to the health condition of asthmatic patients. It indicates when β2 agonist drugs are used during monotherapy, it triggers bronchial hyper-responsiveness (BHR) and results to an increase in the allergen-induced early and late asthmatic...

  • Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction. Schaafsma, Dedmer; Bos, I. Sophie T.; Zuidhof, Annet B.; Zaagsma, Johan; Meurs, Herman // Respiratory Research;2006, Vol. 7, p121 

    Background: In guinea pigs, we have previously demonstrated that the contribution of Rho-kinase to airway responsiveness in vivo and ex vivo is enhanced after active sensitization with ovalbumin (OA). Using conscious, unrestrained OA-sensitized guina pigs, we now investigated the role of...

  • Effects of an Eosinophil Chemotaxis Inhibitor, TAK-661, on Antigen-Induced Asthmatic Responses in Allergic Sheep. Fujimoto, K.; Tsunoda, T.; Koizumi, T.; Kubo, K. // Lung;2002, Vol. 180 Issue 3, p161 

    Eosinophils have been shown to play a role in allergen-induced airway responses. The aim in this study was to examine the effects of TAK-661, a newly developed product as a specific inhibitory agent of eosinophil chemotaxis, on antigen-induced asthmatic responses in allergic sheep model. Seven...

  • Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Gauvreau, Gail M.; Boulet, Louis-Philippe; Schmid-Wirlitsch, Christine; Côté, Johanne; Duong, MyLinh; Killian, Kieran J.; Milot, Joanne; Deschesnes, Francine; Strinich, Tara; Watson, Richard M.; Bredenbröker, Dirk; O'Byrne, Paul M. // Respiratory Research;Oct2011, Vol. 12 Issue 10, p1 

    Background: Phosphodiesterase 4 (PDE4) inhibitors increase intracellular cyclic adenosine monophosphate (cAMP), leading to regulation of inflammatory cell functions. Roflumilast is a potent and targeted PDE4 inhibitor. The objective of this study was to evaluate the effects of roflumilast on...

  • Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study. Singh, Dave; Boyce, Malcolm; Norris, Virginia; Kent, Sandra E.; Bentley, Jane H. // International Journal of General Medicine;2013, Vol. 6, p897 

    Background: GSK2190915, a 5-lipoxygenase activating protein inhibitor, inhibits the production of cysteinyl leukotrienes and leukotriene B4 and 5-oxo-6,8,11,14-eicosatetraenoic acid. We have previously reported that GSK2190915 100 mg daily inhibits early and late asthmatic responses to inhaled...

  • Breathe deep. Hewitt, Allison // Pharmaceutical Executive;Mar1998, Vol. 18 Issue 3, p118 

    Reports that ICOS Corp. has initiated a Phase II clinical trial of rPlatelet-activating factor-AH in patients with asthma. Aim of the study to evaluate the safety and effectiveness of the product on allergen-induced asthmatic response.

  • Platelet-Activating Factor Antagonists: Current Status in Asthma. Gomez, F.P.; Rodriguez-Roisin, R. // BioDrugs;2000, Vol. 14 Issue 1, p21 

    Platelet-activating factor (PAF) is a potent lipid-derived mediator of inflammation that is considered to have a potential role in the pathogenesis of asthma. PAF is produced by many cells associated with asthmatic inflammation and has the ability to evoke some of the clinical hallmarks of...

  • The Effect of Inhaled Heparin on Airway Responsiveness to Histamine and Leukotriene D[sub4]. Stelmach, Iwona; Jerzynska, Joanna; Stelmach, Wlodzimierz; Majak, Pawel; Brzozowska, Agnieszka; Gorski, Pawel; Kuna, Piotr // Allergy & Asthma Proceedings;Jan/Feb2003, Vol. 24 Issue 1, p59 

    Inhaled heparin has been shown to reduce the early and late phase of asthmatic reactions and suppress an allergen-induced increase in bronchial hyperreactivity. The mechanism involved in the control of bronchial hyperreactivity in asthma by heparin is still not understood. The purpose of...

  • Gene-Metabolite Expression in Blood Can Discriminate Allergen-Induced Isolated Early from Dual Asthmatic Responses. Singh, Amrit; Yamamoto, Masatsugu; Kam, Sarah H. Y.; Ruan, Jian; Gauvreau, Gail M.; O'Byrne, Paul M.; FitzGerald, J. Mark; Schellenberg, Robert; Boulet, Louis-Philippe; Wojewodka, Gabriella; Kanagaratham, Cynthia; De Sanctis, Juan B.; Radzioch, Danuta; Tebbutt, Scott J. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Some asthmatic individuals undergoing allergen inhalation challenge develop an isolated early response whereas others develop a dual response (early plus late response). In the present study we have used transcriptomics (microarrays) and metabolomics (mass spectrometry) of peripheral blood to...

  • Low plasma cortisol concentrations during late asthmatic responses. Nakazawa, Tsugio; Umegae, Yoshio; Matsui, Shigeru; Kobayashi, Setsuo // British Medical Journal (Clinical Research Edition);9/28/1985, Vol. 291 Issue 6499, p867 

    Investigates low plasma cortisol concentrations during late asthmatic responses. Measurement of serial plasma cortisol concentrations; Description of the pathophysiological mechanism of late asthmatic responses; Speculation on the insufficiency of the production of steroids to block late...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics